ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 664266 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 664266; 2) Community: the network communities that were significantly associated with the response to NSC 664266; 3) Molecule: the relationships between components within communities and NSC 664266; 4) MDR: the compounds that were significantly associated with the NSC 664266.

NSC Compound Enrichment Correlation
NSC 699671 Null 0.00896740831404549 0.56025019
NSC 81052 Streptonigrin analog (MeO-N3) 0.00896740831404549 0.52012188
NSC 144173 Quinoxaline, 2,3-bis(iodomethyl)-6-methoxy- 0.00896740831404562 0.56791561
NSC 632790 Platinum, dichloro(quinoline-N)[sulfinylbis(methane)-S]-, (SP-4-1) 0.00896740831404562 0.54389673
NSC 651590 ANTINEOPLASTIC-651590 0.00896740831404562 0.61653472
NSC 662383 2-Bromo-5,8-dihydroxy-3-methyl-1,4-naphthoquinone 0.00896740831404562 0.57554777
NSC 118218 2-Fluoro Ara A 0.00910228844192553 0.1102973
NSC 343378 1H-Indene-1,3(2H)-dione, 2-[[(2-methylphenyl)imino]phenylmethyl]- 0.00910228844192553 0.002692844
NSC 50273 Pyridine, 3-[[4-[bis(2-chloroethyl)amino]-2-methylbenzylidene]amino]- 0.00910228844192553 -0.054304666
NSC 526333 2,5-Cyclohexadiene-.delta.(1,.alpha.)-acetonitrile, 4-oxo-.alpha.-phenyl-, O-acetyloxime 0.00910228844192553 0.35900377
Total:170  Current:62    [First] [Prev] [Next] [Last]